cft

Biopharmaceutical Contract Manufacturing Market Size Worth USD 17.9 Billion, Globally, By 2030 At 9.5% CAGR.

The global biopharmaceutical contract manufacturing market has grown steadily in recent years. It is expected to grow at a CAGR of 9.5% between 2023 and 2030.The market was valued at USD 8.8 Billion in 2022and is expected to reach USD 17.9 Billion in 2030.


user

Vanshika Shukla

8 months ago | 4 min read

The latest market report published by Credence Research, Inc. “Global Biopharmaceutical Contract Manufacturing Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028.The global biopharmaceutical contract manufacturing market has grown steadily in recent years. It is expected to grow at a CAGR of 9.5% between 2023 and 2030.The market was valued at USD 8.8 Billion in 2022and is expected to reach USD 17.9 Billion in 2030.

Biopharmaceutical Contract Manufacturing Market current trends reflect the dynamic and ever-evolving landscape of the biopharmaceutical industry. As novel therapies and advanced medicines continue to emerge, pharmaceutical companies are increasingly relying on contract manufacturing organizations (CMOs) to meet their production needs while ensuring cost-efficiency and flexibility. One notable trend in this market is the growing demand for personalized medicine, which requires tailored manufacturing processes. CMOs are adapting by investing in specialized facilities equipped with cutting-edge technologies such as continuous manufacturing platforms and single-use systems that enable efficient production of small batch sizes, reducing time-to-market for these customized treatments.

The biopharmaceutical industry has been witnessing substantial growth due to advancements in biotechnology and the rising prevalence of chronic diseases worldwide. The development of complex biologics and personalized medicine has further fueled the demand for efficient contract manufacturing services.

Outsourcing Trend Boosting Market Expansion

The trend of outsourcing biopharmaceutical manufacturing activities has gained traction in recent years, as pharmaceutical companies seek to focus on their core competencies, such as research and development, while relying on specialized contract manufacturing organizations (CMOs) for manufacturing and production. Outsourcing allows companies to reduce capital investment and operational costs while accessing state-of-the-art facilities and expertise of established CMOs.

Key Market Drivers and Opportunities

The Biopharmaceuticals Contract Manufacturing Market is driven by several key factors, including:

1. Rising Demand for Biologics: The increasing demand for biologics, including monoclonal antibodies, recombinant proteins, and vaccines, has stimulated the need for contract manufacturing services. Biologics offer targeted therapies and novel treatment options for various diseases, prompting pharmaceutical companies to outsource manufacturing to meet the rising demand.

2. Growing Complexity of Biopharmaceuticals: The complexity of biopharmaceutical products requires specialized manufacturing capabilities and stringent quality control measures. Contract manufacturing organizations equipped with advanced technology and regulatory expertise are better positioned to produce these complex biologics efficiently.

3. Advancements in Bioprocessing Technology: Continuous innovations in bioprocessing technologies, such as single-use systems, perfusion bioreactors, and cell culture media, have enhanced the productivity and cost-effectiveness of biopharmaceutical manufacturing. CMOs adopting these advanced technologies gain a competitive advantage in the market.

4. Expansion of Biopharmaceutical Pipelines: The robust growth of biopharmaceutical pipelines, driven by extensive research and development activities, has led to an increased need for contract manufacturing services. As pharmaceutical companies seek to expedite the development and commercialization of their products, outsourcing manufacturing processes becomes a strategic option.

5. Growing Biosimilars Market: The emergence of biosimilars as cost-effective alternatives to originator biologics has boosted their adoption worldwide. Contract manufacturing organizations play a crucial role in the production of biosimilars, contributing to the market growth.

Browse 190 pages reportBiopharmaceutical Contract Manufacturing Market By Source (Mammalian, Non-mammalian) By Service (Process Development, Downstream., Upstream, Fill & Finish Operations, Analytical & QC studies, Packaging) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)-https://www.credenceresearch.com/report/biopharmaceutical-contract-manufacturing-market

North America Leads the Market

North America holds the largest share in the Biopharmaceuticals Contract Manufacturing Market and is expected to maintain its dominance during the forecast period. The region's well-established biopharmaceutical industry, favorable regulatory environment, and significant investments in biotechnology research contribute to its market leadership.

Asia Pacific: A Lucrative Market

Asia Pacific is emerging as a lucrative market for biopharmaceutical contract manufacturing services. The region offers cost-effective manufacturing solutions and a large pool of skilled workforce, making it an attractive destination for outsourcing biopharmaceutical production.

Conclusion

The Biopharmaceuticals Contract Manufacturing Market is witnessing significant growth, driven by the increasing trend of outsourcing and the growing demand for biologics. As pharmaceutical companies focus on innovation and pipeline expansion, contract manufacturing organizations play a crucial role in meeting the manufacturing needs of the industry. North America remains a dominant market, while Asia Pacific presents promising growth opportunities.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Biopharmaceutical Contract Manufacturing Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Biopharmaceutical Contract Manufacturing Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report:https://www.credenceresearch.com/report/biopharmaceutical-contract-manufacturing-market

Visit:https://www.credenceresearch.com/

Related Report:https://www.credenceresearch.com/report/temperature-sensitive-packaging-market

Related Report:https://www.credenceresearch.com/report/seaweed-coated-carton-market

Browse Our Blog: https://www.linkedin.com/pulse/biopharmaceutical-contract-manufacturing-market-share-priyanshi-singh

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

Upvote


user
Created by

Vanshika Shukla


people
Post

Upvote

Downvote

Comment

Bookmark

Share


Related Articles